Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
17,76 EUR | +0,68% | +0,91% | +6,92% |
11/04 | Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024 | |
11/04 | Fagron fornisce una guida agli utili per l'anno fiscale 2024 | CI |
Attività
Numero di dipendenti: 3 282
Vendite per attività
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Fagron North America
40,5
%
| 245 | 35,8 % | 309 | 40,5 % | +25,99% |
Fagron EMEA
37,3
%
| 276 | 40,4 % | 285 | 37,3 % | +3,08% |
Fagron Latin America
22,2
%
| 162 | 23,7 % | 169 | 22,2 % | +4,25% |
Vendite per regione
EUR in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
North America
40,5
%
| 245 | 35,8 % | 309 | 40,5 % | +25,99% |
EMEA
37,3
%
| 276 | 40,4 % | 285 | 37,3 % | +3,08% |
Latin America
22,2
%
| 162 | 23,7 % | 169 | 22,2 % | +4,25% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 46 | 27/11/17 | |
Karin de Jong
DFI | Director of Finance/CFO | 45 | 01/05/08 |
Vera Bakker
COO | Chief Operating Officer | 52 | 09/05/22 |
Karen Berg
IRC | Investor Relations Contact | - | 01/09/21 |
Marc van der Aa
PRN | Corporate Officer/Principal | - | - |
Johan Verlinden
LAW | General Counsel | - | 01/04/13 |
Corporate Officer/Principal | 54 | 01/01/08 | |
Celine Caveye
HRO | Human Resources Officer | - | 01/01/11 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Koen Hoffman
CHM | Chairman | 56 | 01/08/16 |
Director/Board Member | 64 | 01/01/19 | |
Chief Executive Officer | 46 | 27/11/17 | |
Karin de Jong
DFI | Director of Finance/CFO | 45 | 01/05/08 |
Director/Board Member | 53 | 09/05/22 | |
Vera Bakker
COO | Chief Operating Officer | 52 | 09/05/22 |
Neeraj Sharma
BRD | Director/Board Member | 52 | 09/05/22 |
Director/Board Member | 53 | 01/01/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 73 228 904 | 69 227 472 ( 94,54 %) | 241 999 ( 0,3305 %) | 94,54 % |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
FAGRON as
FAGRON as Pharmaceuticals: MajorHealth Technology FAGRON as operates as wholesaler of pharmaceutical raw materials, creams and packaging to pharmacists. The company was founded on May 11, 1992 and is headquartered in Olomouc, Czech Republic. |
Pharmaceuticals: Major
|
Arseus Capital NV
Arseus Capital NV Financial ConglomeratesFinance Part of Fagron NV, Arseus Capital NV provides financial services. The private company is based in Nazareth, Belgium. The CEO of the Belgian company is Cornelia de Jong. |
Financial Conglomerates
|
Dr. Kulich Pharma sro
Dr. Kulich Pharma sro Pharmaceuticals: MajorHealth Technology Dr. Kulich Pharma sro engages in the pharmaceuticals industry. It offers drugs, pharmaceutical materials, chemicals, as well as laboratory services. The company was founded by Jan Kulich in 1992 and is headquartered in Hradec Kralove, Czech Republic. |
Pharmaceuticals: Major
|
Fagron BV
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Utili annuali - Indice di sorpresa
Variaz. 1 gen. | Capi. | |
---|---|---|
+6,92% | 1,38 Mrd | |
+25,83% | 661 Mrd | |
+27,00% | 566 Mrd | |
-6,76% | 352 Mrd | |
+20,34% | 332 Mrd | |
+3,00% | 283 Mrd | |
+13,09% | 231 Mrd | |
+5,46% | 200 Mrd | |
-9,61% | 195 Mrd | |
-6,26% | 145 Mrd |
- Borsa valori
- Azioni
- Azione FAGR
- Società Fagron N.V.